Disease: Rotavirus
Applied To: Infants, Children, Adolescents, Adults
Recommended Time: First dose at 6–8 weeks, second dose at 4–6 weeks after first dose, third dose (if applicable) at 14–16 weeks
Route: Rotavirus Vaccine, Live Attenuated (Oral) is for ORAL ADMINISTRATION ONLY AND MUST NOT BE ADMINISTERED PARENTERALLY
Disease: Rotavirus
Applied To: Infants, Children, Adolescents, Adults
Recommended Time: First dose at 6–8 weeks, second dose at 4–6 weeks after first dose, third dose (if applicable) at 14–16 weeks
Route: ROTASIIL-Liquid is for ORAL ADMINISTRATION ONLY AND MUST NOT BE ADMINISTERED PARENTERALLY
Disease: Diphtheria, Tetanus, Pertussis (Whooping Cough), Hepatitis B, Poliomyelitis, Hib (Haemophilus influenzae type b)
Applied To: Infants, Young Children
Recommended Time: Primary: 6, 10, and 14 weeks of age | Booster: 12–24 months
Route: Intramuscular Injection
Disease: Diphtheria, Tetanus, Pertussis, Hepatitis B, Hib
Applied To: Infants, Young Children
Recommended Time: As part of primary immunization schedule
Route: Intramuscular Injection
Disease: Diphtheria, Tetanus, Pertussis, Hib
Applied To: Infants, Young Children
Recommended Time: As part of primary immunization schedule
Route: Intramuscular Injection
Disease: Human Papillomavirus (genital warts, cervical cancer)
Applied To: Infants, Children, Adolescents, Adults
Recommended Time: Before onset of sexual activity (2 or 3 dose schedule)
Route: Intramuscular
Disease: Hepatitis B
Applied To: Infants, Children, Adolescents, Adults
Recommended Time: Birth, then at 6 weeks and 6 months
Route: Intramuscular
Disease: Rabies (post-exposure prophylaxis)
Applied To: Infants, Children, Adolescents, Adults
Recommended Time: Immediately after suspected exposure
Route: Infiltration (local)
Disease: Anemia (CKD, cancer, surgery-related)
Applied To: Infants, Children, Adolescents, Adults
Recommended Time: As prescribed during treatment
Route: Subcutaneous (SC) or Intravenous (IV)
Disease: Anemia (various causes)
Applied To: Infants, Children, Adolescents, Adults
Recommended Time: As prescribed during clinical need
Route: Subcutaneous (SC) or Intravenous (IV)
